Clinical Trials Directory

Trials / Completed

CompletedNCT00141401

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
240 (planned)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin

Timeline

Start date
1999-09-01
Completion
2005-07-01
First posted
2005-09-01
Last updated
2007-08-17

Source: ClinicalTrials.gov record NCT00141401. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. (NCT00141401) · Clinical Trials Directory